CAS: 20733-10-2; 4-Hydroxypyridazine

该化合物是一个多用途的有机化合物,以其不同的化学特性而闻名.它作为各种合成途径的一个构件,具有高度的回活动性和与多种功能组群的兼容性.它的存在加强了化学反应的稳定性和效力,使其成为制药,农用化学和精细化学工业不可或缺的中间体.Pyridazin-4-ol 的结构特征为医药化学提供了独特的机会,为新型治疗剂的发展作出了贡献.

结构式图片

相似化合物

20733-11-3 1415928-75-4 1245643-70-2

欧盟法规

C&L通报

上下游产品

3,6-dichloropyridazin-4-ol

合成工艺路线路线简述

    📜3,6-二氯哒嗪-4-醇置于palladium On Activated Charcoal,乙醇体系中,化学反应生成4-羟基哒嗪
    参考文献:杂环研究中的化学研究.16. Mitteilung.哒嗪.3,4,6-三氯哒嗪取代
    标题:杂环研究中的化学研究.16. Mitteilung.哒嗪.3,4,6-三氯哒嗪取代
    摘要:3,4,6-三氯哒嗪被转化为许多新化合物,其结构由其化学和光谱性质确定.
    Doi:10.1002/hlca.19560390634

    海关参考信息

    专利信息


    专利号:US-6025492-A
    优先权日:1996-08-30
    标 题 :Synthesis of a hydrazone β-keto ester by the reaction with a diazo ester
    发明人:SHAH AJIT S; CLARK JERRY D; MA YINONG; PETERSON JAMES C; PATELIS LEFTERIS
    权利人:MONSANTO CO
    摘要:The present invention relates to the synthesis of a hydrazone β-keto ester by the reaction of an alkyl diazoester with a hydrazone aldehyde in the presence of a Lewis acid In a preferred embodiment, the hydrazone β-keto ester is then converted into a pyridazinone compound by the reaction with an alkyl acid chloride in the presence of a base, followed by acidification. A process for the production of a hydrazone aldehyde, which comprises contacting a hydrazine and glyoxal, is also described.

    专利号:EP-0923540-B1
    优先权日:1996-08-30
    标题 :Synthesis of a hydrazone beta-keto ester by the reaction with a diazo ester
    发明人:SHAH AJIT S; CLARK JERRY D; MA YINONG; PETERSON JAMES C; PATELIS LEFTERIS
    权利人:MONSANTO TECHNOLOGY LLC
    摘要:The present invention relates to the synthesis of a hydrazone β-keto ester by the reaction of an alkyl diazo ester with a hydrazone aldehyde in the presence of a Lewis acid. In a preferred embodiment, the hydrazone β-keto ester is then converted into a pyridazinone compound by the reaction with an alkyl acid chloride in the presence of a base, followed by acidification. The present invention also relates to a continuous process for the production of a hydrazone aldehyde comprising contacting a hydrazine and glyoxal, wherein the hydrazine and the glyoxal are added simultaneously to a reactor at a controlled rate.

    专利号:WO-2023086799-A1
    优先权日:2021-11-09
    标 题:Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists
    发明人:HOUZE JONATHAN B; PANDYA BHAUMIK; KAPLAN ALAN P
    权利人:VIGIL NEUROSCIENCE INC
    摘要:The present disclosure provides compounds of Formula I, useful for the activation of Triggering Receptor Expressed on Myeloid Cells 2 ('TREM2'). This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a neurodegenerative disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula I.

    专利号:WO-9808807-A1
    优先权日:1996-08-30
    标题:SYNTHESIS OF A HYDRAZONE β-KETO ESTER BY THE REACTION WITH A DIAZO ESTER

    专利号:EP-0923540-A1
    优先权日:1996-08-30
    标 题:Synthesis of a hydrazone beta-keto ester by the reaction with a diazo ester

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:A. Albert and J. N. Phillips. J. Chem. Soc. 1956, 1294.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知